08.01.2008 14:00:00
|
Exogen Signs Major Data Migration Contract
Exogen, a business solutions company focused on creating value for
healthcare providers and manufacturers, and wholly-owned subsidiary of
Technology Solutions Company (NASDAQ:TSCC), announced today that it was
chosen by North Shore-Long Island Jewish Health System to manage the
data migration and consolidation of medical image data from its legacy
systems to their enterprise medical image storage system. Exogen’s
Data Certainty solution combines its newly developed, patent-pending
technology with its value focused professional services to provide the
industry’s most comprehensive approach to
analyzing, characterizing, cleansing and ensuring the migrating of
legacy medical image data into a consolidated enterprise approach.
"Exogen’s Data
Certainty approach is unique,” commented John
Bosco, Chief Information Officer, North Shore-LIJ Health System. "Unlike
other data migration solutions we have used in the past or have
investigated, Exogen takes a very holistic and complete approach to
ensuring the integrity and migration of our data. Prior to moving one
pixel of data, they were able to characterize our legacy data, tell us
what was good and bad, what could be cleansed, and how fast the
migration would take. This compares to the industry norm where vendors
either provide you a piece of software to move the data yourself or
worse, they begin moving data without regard to its integrity or impact
to the organization.” "We are pleased to have been chosen by this
prestigious Health System to assist them with their data management
needs,” said Milton Silva-Craig, President
and CEO of Exogen. "After several years of
working with clients on data migration projects and developing a deep
understanding of the challenges associated with migrating large amounts
of proprietary and inconsistent data, we came to the realization that
there were opportunities for significant improvements in innovation and
process which would enhance the data migration experience resulting in
more direct and tangible customer value creation. We look forward to
helping North Shore-LIJ leverage their medical image data in a more
meaningful manner.” ABOUT NORTH SHORE-LIJ HEALTH SYSTEM
The nation's third largest, non-profit, secular healthcare system, the
North Shore-LIJ Health System cares for people of all ages throughout
Long Island, Queens and Staten Island – a
service area encompassing more than five million people. Including its
clinical affiliates, the health system consists of 16 hospitals, 13
long-term care facilities, a medical research institute, four trauma
centers, five home health agencies and dozens of outpatient centers. The
members and affiliates of North Shore-LIJ house more than 9,300 beds,
and are staffed by over 8,000 physicians, about 11,000 nurses and a
total workforce of more than 38,000 – the
largest employer on Long Island and the ninth largest in New York City.
ABOUT EXOGEN
Exogen is a business solutions company that is focused on creating value
for healthcare providers and manufacturers. Our solutions help lead the
transformation of healthcare providers and manufacturers from a
traditional inside-out thinking to an Outside-In value-driven customer
perspective. Our teams of value creation experts have intimate knowledge
of the challenges facing healthcare providers and manufacturers today
and share a common vision for the future. We combine our knowledge and
vision, with best-in-class solutions developed in other industries, to
bring to market unique products and services for healthcare providers
and manufacturers. We refer to our industry leading solutions as
Experience and Certainty. Our proven Experience solutions leverage our
exclusive Outside-In intellectual property helping our customers
identify, understand and quantify value creation opportunities through
the eyes of their customers. Our proven Certainty solutions deliver and
sustain value in the areas of digital healthcare and operational
transformation. Our entire suite of business solutions exist to deliver
results. We have delivered hundreds of successful strategy, planning,
implementation and optimization projects with extraordinary results and
outstanding client references. For more information, please visit: www.exogeninc.com.
Exogen is a wholly-owned subsidiary of Technology Solutions Company.
ABOUT TSC
Technology Solutions Company (TSC) is a leading business solutions
provider that partners with clients to expose and leverage opportunities
that create, measure, and sustain the delivery of value to their
customers. TSC serves the healthcare and manufacturing industries. For
more information, please visit: www.techsol.com.
CERTAIN FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE
RESULTS This press release contains or may contain certain forward-looking
statements concerning TSC’s financial
position, results of operations, cash flows, business strategy, budgets,
projected costs and plans and objectives of management for future
operations as well as other statements including words such as "anticipate,” "believe,” "plan,” "estimate,” "expect,” "intend,” and
other similar expressions. These forward-looking statements involve
significant risks and uncertainties. Although TSC believes that the
expectations reflected in such forward-looking statements are based on
reasonable assumptions, readers are cautioned that no assurance can be
given that such expectations will prove correct and that actual results
and developments may differ materially from those conveyed in such
forward-looking statements. TSC claims the protection of the safe harbor
for forward-looking statements contained in the Private Securities
Litigation Reform Act of 1995 for all forward-looking statements.
Important factors that could cause actual results to differ materially
from the expectations reflected in the forward-looking statements in
this press release include, among others, TSC's ability to manage
decreased revenue levels; TSC's need to attract new business and
increase revenues; TSC's declining cash position; TSC's ability to
manage costs and headcount relative to expected revenues; TSC's ability
to successfully introduce new product and service offerings; TSC's
ability to successfully introduce its new Exogen business subsidiary;
TSC's dependence on a limited number of clients for a large portion of
its revenue; the potential loss of significant clients; TSC's
ability to attract new clients and sell additional work to existing
clients; TSC's ability to attract and retain employees; the
rapidly changing nature of information technology services, including
TSC's ability to keep pace with technological and market changes and its
ability to refine and add to existing service offerings; the lack
of shareholder approved stock options available for grants by TSC to
retain existing employees; and changing business, economic or market
conditions and changes in competitive and other factors, all as more
fully described herein and in TSC's filings with the Securities and
Exchange Commission, press releases and other communications.
Forward-looking statements are not guarantees of performance. Such
forward-looking statements speak only as of the date on which they are
made and, except as may be otherwise required by law, TSC does not
undertake any obligation to update any forward-looking statement to
reflect events or circumstances after the date of this press release. If
TSC does update or correct one or more forward-looking statements,
investors and others should not conclude that TSC will make additional
updates or corrections with respect thereto or with respect to other
forward-looking statements. Actual results may vary materially.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Technology Solutions Co.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Technology Solutions Co.mehr Analysen
Aktien in diesem Artikel
Technology Solutions Co. | 0,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 054,84 | 0,27% |